Ing Groep Nv Abbott Laboratories Transaction History

Ing Groep Nv

$16.5 Billion
Q3 2024

A detailed history of Ing Groep Nv transactions in Abbott Laboratories stock. As of the latest transaction made, Ing Groep Nv holds 452,790 shares of ABT stock, worth $51.7 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

452,790

Previous 429,795 5.35%

Holding current value

$51.7 Million

Previous $44.7 Million 15.59%

% of portfolio

0.31%

Previous 0.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$100.07 - $118.13 $2.3 Million - $2.72 Million	22,995 Added 5.35%	452,790 $51.6 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $15.4 Million - $17.1 Million	152,403 Added 54.94%	429,795 $44.7 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $515,948 - $569,842	4,711 Added 1.73%	277,392 $31.5 Million
Q4 2023 Feb 08, 2024	SELL	$90.19 - $110.4 $62.7 Million - $76.8 Million	-695,432 Reduced 71.83%	272,681 $30 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $629,160 - $754,887	-6,586 Reduced 0.68%	968,113 $93.8 Million
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $59.7 Million - $66.5 Million	592,307 Added 154.9%	974,699 $106 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $35.8 Million - $42.1 Million	369,205 Added 2799.76%	382,392 $38.7 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $15.1 Million - $17.8 Million	-159,274 Reduced 92.35%	13,187 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $15 Million - $17.4 Million	-155,019 Reduced 47.34%	172,461 $16.7 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $15.5 Million - $18.7 Million	-151,777 Reduced 31.67%	327,480 $35.6 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $11.2 Million - $13.7 Million	-98,386 Reduced 17.03%	479,257 $56.7 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $32.6 Million - $40 Million	282,472 Added 95.7%	577,643 $81.3 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $127,742 - $141,320	-1,095 Reduced 0.37%	295,171 $34.9 Million
Q2 2021 Aug 13, 2021	BUY	$105.79 - $124.53 $3.31 Million - $3.9 Million	31,321 Added 11.82%	296,266 $34.3 Million
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $15.6 Million - $18.3 Million	142,884 Added 117.06%	264,945 $31.8 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $8.24 Million - $8.98 Million	78,449 Added 179.88%	122,061 $13.4 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $1.7 Million - $2.06 Million	18,524 Added 73.84%	43,612 $4.75 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $1.92 Million - $2.46 Million	25,088 New	25,088 $2.29 Million
Q1 2020 May 06, 2020	SELL	$62.82 - $91.86 $1.56 Million - $2.28 Million	-24,858 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $4.94 Million - $5.5 Million	-62,873 Reduced 71.67%	24,858 $2.16 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $2.68 Million - $2.91 Million	32,743 Added 59.55%	87,731 $7.34 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $3.13 Million - $3.65 Million	42,954 Added 356.94%	54,988 $4.62 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $3.79 Million - $4.58 Million	-57,250 Reduced 82.63%	12,034 $962,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $2.78 Million - $3.15 Million	-42,405 Reduced 37.97%	69,284 $5.01 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $6.07 Million - $7.32 Million	99,830 Added 841.81%	111,689 $8.19 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $10.2 Million - $11.3 Million	-177,519 Reduced 93.74%	11,859 $723,000
Q1 2018 May 07, 2018	BUY	$56.27 - $63.62 $4.07 Million - $4.6 Million	72,345 Added 61.82%	189,378 $11.3 Million
Q4 2017 Feb 06, 2018	BUY	$53.68 - $57.47 $5.63 Million - $6.03 Million	104,853 Added 860.86%	117,033 $6.68 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $585,370 - $653,335	12,180	12,180 $650,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account